Arginine 719 in human plasminogen mediates formation of the Staphylokinase:Plasmin activator complex

被引:13
作者
Jespers, L
Van Herzeele, N
Lijnen, HR
Van Hoef, B
De Maeyer, M
Collen, D
Lasters, I
机构
[1] Flanders Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3001 Leuven, Belgium
关键词
D O I
10.1021/bi972807i
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staphylokinase (Sak), a 16-kDa bacterial protein, forms a 1:1 stoichiometric complex with the serine proteinase domain of human plasmin, which in turn converts other plasminogen molecules into plasmin. To identify amino acid residues critical for generating the Sak:plasmin activator complex, alanine-scanning mutagenesis was performed on phage-displayed micro-plasminogen (mu Plg). Substitution of Arg719 with Ala [mu Plg(R719A)] disrupted complex formation, although the sensitivity of phage-displayed mu Plg(R719A) to activation by urokinase and the amidolytic activity of the micro-plasmin derivative [mu Pli(R719A)] remained unaffected. Likewise, the soluble mu Plg(R719A) molecule did not generate a functional activator complex with Sak, whereas quantitative activation into plasmin was obtained upon incubation with either urokinase or the Sak:plasmin complex. Real-time biospecific affinity measurements revealed that the Arg-->Ala substitution at position 719 increased the equilibrium dissociation constant between mu Plg(R719A) and Sak from 46 nM to 1 mu M, primarily by reducing the association rate constant. Arg719 has recently also been implied in the functional complex formation between human plasmin and streptokinase [Dawson, K. M., Marshall, J. M., Raper, R. H., Gilbert, R. J., and Ponting, C. P. (1994) Biochemistry 33, 12042-12047.], suggesting that both bacterial cofactors may share common structural and/or mechanistic aspects for plasminogen activation.
引用
收藏
页码:6380 / 6386
页数:7
相关论文
共 36 条
[1]   KINETICS OF THE REACTIONS BETWEEN STREPTOKINASE, PLASMIN AND ALPHA-2-ANTIPLASMIN [J].
CEDERHOLMWILLIAMS, SA ;
DECOCK, F ;
LIJNEN, HR ;
COLLEN, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 100 (01) :125-132
[2]   MODELING THE POLYPEPTIDE BACKBONE WITH SPARE PARTS FROM KNOWN PROTEIN STRUCTURES [J].
CLAESSENS, M ;
VANCUTSEM, E ;
LASTERS, I ;
WODAK, S .
PROTEIN ENGINEERING, 1989, 2 (05) :335-345
[3]   STAPHYLOKINASE, A FIBRIN-SPECIFIC PLASMINOGEN-ACTIVATOR WITH THERAPEUTIC POTENTIAL [J].
COLLEN, D ;
LIJNEN, HR .
BLOOD, 1994, 84 (03) :680-686
[4]   ISOLATION AND CONDITIONING OF RECOMBINANT STAPHYLOKINASE FOR USE IN MAN [J].
COLLEN, D ;
DEMOL, M ;
DEMARSIN, E ;
DECOCK, F ;
STASSEN, JM .
FIBRINOLYSIS, 1993, 7 (04) :242-247
[5]  
COLLEN D, 1994, MOL BASIS BLOOD DIS, P725
[6]   PLASMINOGEN-ACTIVATOR ACTIVITIES OF EQUIMOLAR COMPLEXES OF STREPTOKINASE WITH VARIANT RECOMBINANT PLASMINOGENS [J].
DAVIDSON, DJ ;
HIGGINS, DL ;
CASTELLINO, FJ .
BIOCHEMISTRY, 1990, 29 (14) :3585-3590
[7]   SUBSTITUTION OF ARGININE-719 FOR GLUTAMIC-ACID IN HUMAN PLASMINOGEN SUBSTANTIALLY REDUCES ITS AFFINITY FOR STREPTOKINASE [J].
DAWSON, KM ;
MARSHALL, JM ;
RAPER, RH ;
GILBERT, RJ ;
PONTING, CP .
BIOCHEMISTRY, 1994, 33 (40) :12042-12047
[8]  
DeMaeyer M, 1997, FOLD DES, V2, P53
[9]   THE DEAD-END ELIMINATION THEOREM AND ITS USE IN PROTEIN SIDE-CHAIN POSITIONING [J].
DESMET, J ;
DEMAEYER, M ;
HAZES, B ;
LASTERS, I .
NATURE, 1992, 356 (6369) :539-542
[10]   PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY [J].
DEUTSCH, DG ;
MERTZ, ET .
SCIENCE, 1970, 170 (3962) :1095-+